Cigna Group has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.
UnitedHealth Group has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.
CVS Health has lagged behind the broader market over the past year, yet Wall Street analysts remain moderately optimistic about the stock’s outlook.
On Sept. 18, 2024, the Federal Reserve implemented its first interest rate cut in four years, reducing the benchmark rate by half a percentage point (50 basis points). This move comes in response to cooling...
Wall Street has seen a somber start to September. Throughout last week, market volatility persisted. Despite initial gains, all three major indexes recorded significant weekly declines. The S&P 500 lost...
Humana underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.
The S&P Global US Manufacturing PMI was revised slightly down to 47.9 in August from a preliminary reading of 48 and hints at the deterioration in the health of the U.S. manufacturing sector so far this...
As HCA Healthcare outperformed relative to the healthcare sector, Wall Street analysts remain optimistic about the stock’s outlook.
Molina Healthcare underperformed the broader market over the past year, but Wall Street analysts remain moderately optimistic about the stock’s prospects.
Elevance Health has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.